Stocks · News reference
This Definium Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Top analysts changed outlook on top names. See analyst ratings page for all changes.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Cantor Fitzgerald Maintains Overweight on Ameresco, Lowers Price Target to $36
Cantor Fitzgerald analyst Manish A. Somaiya maintains Ameresco (NYSE:AMRC) with a Overweight and lowers the price target from $44 to $36.
Ameresco shares are trading lower. The company announced the departure of its CFO, Mark Chiplock.
8-K filing — Ameresco, Inc. (AMRC)
Filed: 2026-08-19 AccNo: 0001628280-26-057986 Size: 145 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Kanzhun Eyes Brazil, Argentina And Vietnam For Growth
The recruitment app operator’s revenue has slowed steadily over the last three years as it solidifies its dominant position in China image credit: Bamboo Works Key Takeaways: Kanzhun’s revenue grew 14.1%
Barclays Maintains Overweight on Kanzhun, Raises Price Target to $20
Barclays analyst Jiong Shao maintains Kanzhun (NASDAQ:BZ) with a Overweight and raises the price target from $19 to $20.